Adjuvant therapy in renal cell carcinoma: current knowledges and future perspectives

Renal cell carcinoma (RCC) constitutes the twelfth most common cancer worldwide, accounting for 3% of all adult malignancies [1].

Source: Cancer Treatment Reviews - April 12, 2021 Category: Cancer & Oncology Authors: Mathieu Larroquette, Florent Peyraud, Charlotte Domblides, F élix Lefort, Jean-Christophe Bernhard, Alain Ravaud, Marine Gross-Goupil Tags: Anti-tumour Treatment Source Type: research